Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort.

ABSTRACT: BACKGROUND:Control of vascular risk factors is essential for secondary stroke prevention. However, adherence to secondary prevention medications is often suboptimal, and may be affected by cognitive impairment. Few studies to date have examined associations between cognitive impairment and medication adherence post-stroke, and none have considered whether adherence to secondary prevention medications might affect subsequent cognitive function. The aim of this study was to explore prospective associations between cognitive impairment and medication non-adherence post-stroke. METHODS:A five-year follow-up of 108 stroke survivors from the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) prospective observational cohort study. Cognitive function was assessed

SUBMITTER: Rohde D 

PROVIDER: S-EPMC6797135 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature